Pfizer’s breast cancer drug combo falls short of survival goal
Ibrance is Pfizer’s blockbuster treatment and is already approved as a combination with endocrine therapy for use in breast cancer…
Author
APCER Life Sciences, ArisGlobal launch integrated PV cloud and services platform
Best of breed PV services and technology platform will redefine regulatory compliance speed, cost and analytical insight paradigm
Piramal subsidiary sells stake in PISA to UK’s Alliance Medical Acquisitionco
Total consideration for this sale is base consideration of $1 plus $ 1,177,682 towards working capital adjustment on completion of…
Aurobindo Pharma’s generic Ertapenem Injection bags US FDA approval
Ertapenem injection is used for the treatment of moderate to severe infections caused by susceptible bacteria
Ideal Cures launches new film coating products at 2nd FDD Conclave
INSTACOAT QD and INSTACOAT T2F are suited for pharmaceutical and nutraceutical applications
Lupin aims to launch around 30 generic products in the US
The drug firm is banking on introduction of complex generics and biosimilars in the US
Aptar Pharma’s multidose dispenser approved by ANSM
Levofree is a prescription product for the treatment of allergic conjunctivitis
ACG Films & Foils launches lamination facility at Shirwal
The company has become a complete packaging solution provider for oral solid dosage formulation for the healthcare sector
AstraZeneca receives DCG(I) nod for Durvalumab in India
Durvalumab provides a treatment option for patient with locally advanced, unresectable Non-Small Cell Lung Cancer
DIL approves Scheme of Amalgamation with subsidiary FBL
Amalgamation to be value accretive to shareholders in addition to other benefits